Applied Therapeutics Inc (APLT)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 2025-03-04 | S Sale |
Chief Medical Officer Officer |
10,366
-1.2%
0.44USD 4,561 |
10,366 -1.2% | 0.44 | USD 4,561 | |
| 2025-03-06 | 2025-03-04 | S Sale |
See Remarks Officer |
447
-0.2%
0.44USD 197 |
447 -0.2% | 0.44 | USD 197 | |
| 2025-03-06 | 2025-03-04 | S Sale |
See Remarks Executive Director |
14,502
-3.6%
0.44USD 6,381 |
14,502 -3.6% | 0.44 | USD 6,381 | |
| 2025-02-07 | 2025-02-06 | S Sale |
Chief Medical Officer Officer |
86,078
-8.7%
0.61USD 52,508 |
86,078 -8.7% | 0.61 | USD 52,508 | |
| 2025-02-07 | 2025-02-06 | S Sale |
See Remarks Officer |
28,117
-9.4%
0.61USD 17,151 |
28,117 -9.4% | 0.61 | USD 17,151 | |
| 2025-02-07 | 2025-02-06 | S Sale |
See Remarks Executive Director |
22,950
-5.4%
0.61USD 14,000 |
22,950 -5.4% | 0.61 | USD 14,000 | |
| 2024-08-23 | 2024-08-22 | S Sale |
Chief Medical Officer Officer |
22,681
-2.2%
5.83USD 132,230 |
22,681 -2.2% | 5.83 | USD 132,230 | |
| 2024-08-23 | 2024-08-22 | S Sale |
Chief Financial Officer Executive Director |
13,530
-4.6%
5.83USD 78,880 |
13,530 -4.6% | 5.83 | USD 78,880 | |
| 2024-08-14 | 2024-08-14 | S Sale |
President and CEO Executive Director |
119,591
-2.5%
5.93USD 709,175 |
119,591 -2.5% | 5.93 | USD 709,175 | |
| 2024-08-14 | 2024-08-13 | S Sale |
President and CEO Executive Director |
357,423
-6.9%
6.18USD 2,208,874 |
357,423 -6.9% | 6.18 | USD 2,208,874 | |
| 2024-08-14 | 2024-08-12 | S Sale |
President and CEO Executive Director |
300,000
-5.5%
5.98USD 1,794,000 |
300,000 -5.5% | 5.98 | USD 1,794,000 | |
| 2024-06-10 | 2024-06-06 | S Sale |
President and CEO Executive Director Large shareholder |
61,795
-1.6%
4.32USD 266,954 |
61,795 -1.6% | 4.32 | USD 266,954 | |
| 2024-06-10 | 2024-06-06 | S Sale |
Chief Financial Officer Executive Director |
16,980
-5.5%
4.32USD 73,354 |
16,980 -5.5% | 4.32 | USD 73,354 | |
| 2024-06-10 | 2024-06-06 | S Sale |
Chief Medical Officer Officer |
22,003
-2.1%
4.32USD 95,053 |
22,003 -2.1% | 4.32 | USD 95,053 | |
| 2024-06-06 | 2024-06-05 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
150,000
-2.5%
4.24USD 636,000 |
150,000 -2.5% | 4.24 | USD 636,000 | |
| 2024-06-06 | 2024-06-04 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
150,000
-2.4%
4.21USD 631,500 |
150,000 -2.4% | 4.21 | USD 631,500 | |
| 2024-03-18 | 2024-03-14 | S Sale |
Chief Commercial Officer Officer |
48,871
-6.3%
5.39USD 263,415 |
48,871 -6.3% | 5.39 | USD 263,415 | |
| 2024-03-18 | 2024-03-14 | S Sale |
Chief Medical Officer Officer |
110,804
-9.7%
5.39USD 597,234 |
110,804 -9.7% | 5.39 | USD 597,234 | |
| 2024-03-18 | 2024-03-14 | S Sale |
Chief Financial Officer Executive Director |
28,727
-8.5%
5.39USD 154,839 |
28,727 -8.5% | 5.39 | USD 154,839 | |
| 2024-03-18 | 2024-03-14 | S Sale |
President and CEO Executive Director Large shareholder |
318,573
-7.7%
5.39USD 1,717,108 |
318,573 -7.7% | 5.39 | USD 1,717,108 | |
| 2023-12-05 | 2023-12-01 | B Purchase | Non-Executive Director |
30,000
+90.9%
2.18USD 65,367 |
30,000 +90.9% | 2.18 | USD 65,367 | |
| 2023-12-01 | 2023-11-30 | S Sale |
President and CEO Executive Director Large shareholder |
3,968
-0.2%
1.97USD 7,817 |
3,968 -0.2% | 1.97 | USD 7,817 | |
| 2023-12-01 | 2023-11-30 | S Sale |
Chief Commercial Officer Officer |
965
-0.3%
1.97USD 1,901 |
965 -0.3% | 1.97 | USD 1,901 | |
| 2023-12-01 | 2023-11-30 | S Sale |
Chief Medical Officer Officer |
1,583
-0.2%
1.97USD 3,119 |
1,583 -0.2% | 1.97 | USD 3,119 | |
| 2023-11-06 | 2023-11-03 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
143,450
-2.5%
2.31USD 331,370 |
143,450 -2.5% | 2.31 | USD 331,370 | |
| 2023-11-06 | 2023-11-02 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
103,808
-1.8%
2.32USD 240,835 |
103,808 -1.8% | 2.32 | USD 240,835 | |
| 2023-11-02 | 2023-11-01 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
172,742
-2.9%
2.36USD 407,671 |
172,742 -2.9% | 2.36 | USD 407,671 | |
| 2023-11-02 | 2023-10-31 | S Sale |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
155,000
-2.5%
2.41USD 373,550 |
155,000 -2.5% | 2.41 | USD 373,550 | |
| 2023-09-29 | 2023-09-27 | S Sale |
Chief Commercial Officer Officer |
9,720
-2.5%
2.70USD 26,244 |
9,720 -2.5% | 2.70 | USD 26,244 | |
| 2023-09-29 | 2023-09-27 | S Sale |
Chief Medical Officer Officer |
10,932
-1.6%
2.70USD 29,516 |
10,932 -1.6% | 2.70 | USD 29,516 | |
| 2023-09-29 | 2023-09-27 | S Sale |
President and CEO Executive Director Large shareholder |
115,632
-4.3%
2.70USD 312,206 |
115,632 -4.3% | 2.70 | USD 312,206 | |
| 2023-01-13 | 2023-01-11 | S Sale |
President and CEO Executive Director Large shareholder |
15,870
-2.1%
0.91USD 14,442 |
15,870 -2.1% | 0.91 | USD 14,442 | |
| 2023-01-13 | 2023-01-11 | S Sale |
Chief Medical Officer Officer |
6,053
-3.8%
0.91USD 5,508 |
6,053 -3.8% | 0.91 | USD 5,508 | |
| 2023-01-13 | 2023-01-11 | S Sale |
Chief Commercial Officer Officer |
4,495
-4.6%
0.91USD 4,090 |
4,495 -4.6% | 0.91 | USD 4,090 | |
| 2022-10-14 | 2022-10-14 | B Purchase |
President and CEO Executive Director Large shareholder |
50,000
+7.0%
0.65USD 32,250 |
50,000 +7.0% | 0.65 | USD 32,250 | |
| 2022-10-13 | 2022-10-13 | B Purchase |
President and CEO Executive Director Large shareholder |
73,256
+11.4%
0.56USD 40,891 |
73,256 +11.4% | 0.56 | USD 40,891 | |
| 2022-10-12 | 2022-10-12 | B Purchase |
President and CEO Executive Director Large shareholder |
38,153
+6.3%
0.52USD 19,943 |
38,153 +6.3% | 0.52 | USD 19,943 | |
| 2022-06-29 | 2022-06-27 | B Purchase |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
2,065,000
+82.9%
1.00USD 2,065,000 |
2,065,000 +82.9% | 1.00 | USD 2,065,000 | |
| 2022-06-29 | 2022-06-27 | B Purchase |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
1,435,000
+152.0%
1.00USD 1,435,000 |
1,435,000 +152.0% | 1.00 | USD 1,435,000 | |
| 2022-05-18 | 2022-05-16 | S Sale |
See Remarks Officer |
905
-8.5%
1.65USD 1,493 |
905 -8.5% | 1.65 | USD 1,493 | |
| 2022-03-23 | 2022-03-23 | B Purchase |
Chief Medical Officer Officer |
30,000
+22.9%
1.97USD 59,100 |
30,000 +22.9% | 1.97 | USD 59,100 | |
| 2022-03-23 | 2022-03-22 | B Purchase |
Chief Medical Officer Officer |
21,961
+20.2%
1.98USD 43,483 |
21,961 +20.2% | 1.98 | USD 43,483 | |
| 2022-03-23 | 2022-03-21 | B Purchase |
Chief Medical Officer Officer |
12,548
+13.0%
1.85USD 23,214 |
12,548 +13.0% | 1.85 | USD 23,214 | |
| 2021-09-14 | 2021-09-14 | B Purchase |
President and CEO Executive Director Large shareholder |
9,300
+2.6%
14.49USD 134,740 |
9,300 +2.6% | 14.49 | USD 134,740 | |
| 2021-09-14 | 2021-09-13 | B Purchase |
President and CEO Executive Director Large shareholder |
701
+0.2%
14.69USD 10,298 |
701 +0.2% | 14.69 | USD 10,298 | |
| 2021-06-10 | 2021-06-08 | S Sale |
Chief Financial Officer Officer |
5,047
-5.4%
21.42USD 108,107 |
5,047 -5.4% | 21.42 | USD 108,107 | |
| 2021-06-07 | 2021-06-07 | PS Planned sale |
Chief Medical Officer Officer |
260
-100.0%
21.38USD 5,559 |
260 -100.0% | 21.38 | USD 5,559 | |
| 2021-06-07 | 2021-06-07 | PS Planned sale |
Chief Medical Officer Officer |
200
-43.5%
20.43USD 4,086 |
200 -43.5% | 20.43 | USD 4,086 | |
| 2021-06-07 | 2021-06-04 | PS Planned sale |
Chief Medical Officer Officer |
460
-100.0%
19.65USD 9,039 |
460 -100.0% | 19.65 | USD 9,039 | |
| 2021-06-07 | 2021-06-03 | PS Planned sale |
Chief Medical Officer Officer |
460
-100.0%
19.66USD 9,044 |
460 -100.0% | 19.66 | USD 9,044 | |
| 2021-05-28 | 2021-05-26 | S Sale |
Chief Commercial Officer Officer |
2,894
-7.9%
18.35USD 53,105 |
2,894 -7.9% | 18.35 | USD 53,105 | |
| 2021-04-30 | 2021-04-30 | PS Planned sale |
Chief Medical Officer Officer |
460
-100.0%
18.32USD 8,427 |
460 -100.0% | 18.32 | USD 8,427 | |
| 2021-04-30 | 2021-04-29 | PS Planned sale |
Chief Medical Officer Officer |
460
-100.0%
18.28USD 8,409 |
460 -100.0% | 18.28 | USD 8,409 | |
| 2021-04-30 | 2021-04-28 | PS Planned sale |
Chief Medical Officer Officer |
300
-100.0%
18.92USD 5,676 |
300 -100.0% | 18.92 | USD 5,676 | |
| 2021-04-30 | 2021-04-28 | PS Planned sale |
Chief Medical Officer Officer |
1,340
-81.7%
18.33USD 24,562 |
1,340 -81.7% | 18.33 | USD 24,562 | |
| 2021-03-30 | 2021-03-30 | PS Planned sale |
Chief Medical Officer Officer |
460
-100.0%
18.43USD 8,478 |
460 -100.0% | 18.43 | USD 8,478 | |
| 2021-03-30 | 2021-03-29 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
18.53USD 8,616 |
465 -100.0% | 18.53 | USD 8,616 | |
| 2021-03-30 | 2021-03-26 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
19.68USD 9,151 |
465 -100.0% | 19.68 | USD 9,151 | |
| 2021-03-15 | 2021-03-15 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
19.61USD 9,119 |
465 -100.0% | 19.61 | USD 9,119 | |
| 2021-03-15 | 2021-03-12 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
19.38USD 9,012 |
465 -100.0% | 19.38 | USD 9,012 | |
| 2021-03-15 | 2021-03-11 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
18.48USD 8,593 |
465 -100.0% | 18.48 | USD 8,593 | |
| 2021-02-25 | 2021-02-25 | PS Planned sale |
Chief Medical Officer Officer |
1,295
-100.0%
23.20USD 30,044 |
1,295 -100.0% | 23.20 | USD 30,044 | |
| 2021-02-25 | 2021-02-24 | PS Planned sale |
Chief Medical Officer Officer |
600
-100.0%
24.57USD 14,742 |
600 -100.0% | 24.57 | USD 14,742 | |
| 2021-02-25 | 2021-02-24 | PS Planned sale |
Chief Medical Officer Officer |
1,525
-71.8%
23.71USD 36,158 |
1,525 -71.8% | 23.71 | USD 36,158 | |
| 2021-02-25 | 2021-02-23 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
21.84USD 10,156 |
465 -100.0% | 21.84 | USD 10,156 | |
| 2021-02-24 | 2021-02-19 | B Purchase | Non-Executive Director |
6,500
+100.0%
22.86USD 148,590 |
6,500 +100.0% | 22.86 | USD 148,590 | |
| 2021-02-19 | 2021-02-17 | B Purchase |
ALEXANDRIA REAL ESTATE EQUITIES, INC. Large shareholder |
43,478
+3.5%
23.00USD 999,994 |
43,478 +3.5% | 23.00 | USD 999,994 | |
| 2021-02-03 | 2021-02-03 | PS Planned sale |
Chief Medical Officer Officer |
600
-100.0%
27.30USD 16,380 |
600 -100.0% | 27.30 | USD 16,380 | |
| 2021-02-03 | 2021-02-03 | PS Planned sale |
Chief Medical Officer Officer |
695
-53.7%
26.35USD 18,313 |
695 -53.7% | 26.35 | USD 18,313 | |
| 2021-02-03 | 2021-02-02 | PS Planned sale |
Chief Medical Officer Officer |
595
-100.0%
27.77USD 16,523 |
595 -100.0% | 27.77 | USD 16,523 | |
| 2021-02-03 | 2021-02-02 | PS Planned sale |
Chief Medical Officer Officer |
700
-54.1%
26.87USD 18,809 |
700 -54.1% | 26.87 | USD 18,809 | |
| 2021-02-03 | 2021-02-01 | PS Planned sale |
Chief Medical Officer Officer |
660
-100.0%
26.43USD 17,444 |
660 -100.0% | 26.43 | USD 17,444 | |
| 2021-02-03 | 2021-02-01 | PS Planned sale |
Chief Medical Officer Officer |
800
-21.1%
24.36USD 19,488 |
800 -21.1% | 24.36 | USD 19,488 | |
| 2021-01-21 | 2021-01-21 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
20.30USD 9,440 |
465 -100.0% | 20.30 | USD 9,440 | |
| 2021-01-21 | 2021-01-20 | PS Planned sale |
Chief Medical Officer Officer |
465
-100.0%
21.08USD 9,802 |
465 -100.0% | 21.08 | USD 9,802 |